SAN FRANCISCO, May 6, 2025 (Globe Newswire) — Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that Scott McIvor, Chief Development Officer at Immusoft, will present recent clinical data in a poster presentation at the American Society of Cell…
Prospectively designed for scalability and re-dosability, Immusoft’s engineered B cells represent the next generation of advanced therapeutics San Francisco, CA., April 8, 2026 — Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that it will present an invited clinical…
